These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


314 related items for PubMed ID: 25925701

  • 1. A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients.
    Bhandari S, Kalra PA, Kothari J, Ambühl PM, Christensen JH, Essaian AM, Thomsen LL, Macdougall IC, Coyne DW.
    Nephrol Dial Transplant; 2015 Sep; 30(9):1577-89. PubMed ID: 25925701
    [Abstract] [Full Text] [Related]

  • 2. Conversion of haemodialysis patients from iron sucrose to iron isomaltoside: a real-world experience.
    Jesus-Silva JA, Lamplugh A, Dhada S, Burton JO, Bhandari S.
    BMC Nephrol; 2020 Jun 03; 21(1):212. PubMed ID: 32493240
    [Abstract] [Full Text] [Related]

  • 3. A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia.
    Kalra PA, Bhandari S, Saxena S, Agarwal D, Wirtz G, Kletzmayr J, Thomsen LL, Coyne DW.
    Nephrol Dial Transplant; 2016 Apr 03; 31(4):646-55. PubMed ID: 26250435
    [Abstract] [Full Text] [Related]

  • 4. Safety and efficacy of iron isomaltoside 1000/ferric derisomaltose versus iron sucrose in patients with chronic kidney disease: the FERWON-NEPHRO randomized, open-label, comparative trial.
    Bhandari S, Kalra PA, Berkowitz M, Belo D, Thomsen LL, Wolf M.
    Nephrol Dial Transplant; 2021 Jan 01; 36(1):111-120. PubMed ID: 32049331
    [Abstract] [Full Text] [Related]

  • 5. A randomized comparison of ferumoxytol and iron sucrose for treating iron deficiency anemia in patients with CKD.
    Macdougall IC, Strauss WE, McLaughlin J, Li Z, Dellanna F, Hertel J.
    Clin J Am Soc Nephrol; 2014 Apr 01; 9(4):705-12. PubMed ID: 24458078
    [Abstract] [Full Text] [Related]

  • 6. A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED).
    Reinisch W, Staun M, Tandon RK, Altorjay I, Thillainayagam AV, Gratzer C, Nijhawan S, Thomsen LL.
    Am J Gastroenterol; 2013 Dec 01; 108(12):1877-88. PubMed ID: 24145678
    [Abstract] [Full Text] [Related]

  • 7. Protocol and baseline data for a prospective open-label explorative randomized single-center comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD).
    Ziedan A, Bhandari S.
    Trials; 2019 Apr 04; 20(1):194. PubMed ID: 30947751
    [Abstract] [Full Text] [Related]

  • 8. A prospective observational study of iron isomaltoside in haemodialysis patients with chronic kidney disease treated for iron deficiency (DINO).
    Mikhail AI, Schön S, Simon S, Brown C, Hegbrant JBA, Jensen G, Moore J, Lundberg LDI.
    BMC Nephrol; 2019 Jan 10; 20(1):13. PubMed ID: 30630452
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intravenous iron isomaltoside improves hemoglobin concentration and iron stores in female iron-deficient blood donors: a randomized double-blind placebo-controlled clinical trial.
    Gybel-Brask M, Seeberg J, Thomsen LL, Johansson PI.
    Transfusion; 2018 Apr 10; 58(4):974-981. PubMed ID: 29424441
    [Abstract] [Full Text] [Related]

  • 12. Treatment of iron deficiency in patients with chronic kidney disease: A prospective observational study of iron isomaltoside (NIMO Scandinavia)
.
    Jensen G, Gøransson LG, Fernström A, Furuland H, Christensen JH.
    Clin Nephrol; 2019 Apr 10; 91(4):246-253. PubMed ID: 30614439
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo.
    Kosch M, Bahner U, Bettger H, Matzkies F, Teschner M, Schaefer RM.
    Nephrol Dial Transplant; 2001 Jun 10; 16(6):1239-44. PubMed ID: 11390726
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A prospective observational study of effectiveness and safety of iron isomaltoside in patients with chronic renal failure and iron deficiency anemia
.
    Biggar P, Leistikow F, Walper A.
    Clin Nephrol; 2016 Dec 10; 86 (2016)(12):310-318. PubMed ID: 27737531
    [Abstract] [Full Text] [Related]

  • 17. High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23.
    Dahlerup JF, Jacobsen BA, van der Woude J, Bark LÅ, Thomsen LL, Lindgren S.
    Scand J Gastroenterol; 2016 Nov 10; 51(11):1332-8. PubMed ID: 27326766
    [Abstract] [Full Text] [Related]

  • 18. NIMO-CKD-UK: a real-world, observational study of iron isomaltoside in patients with iron deficiency anaemia and chronic kidney disease.
    Kalra PA, Bhandari S, Spyridon M, Davison R, Lawman S, Mikhail A, Reaich D, Pritchard N, McCafferty K, Moore J.
    BMC Nephrol; 2020 Dec 10; 21(1):539. PubMed ID: 33302891
    [Abstract] [Full Text] [Related]

  • 19. The safety and efficacy of intravenous ferric carboxymaltose in anaemic patients undergoing haemodialysis: a multi-centre, open-label, clinical study.
    Covic A, Mircescu G.
    Nephrol Dial Transplant; 2010 Aug 10; 25(8):2722-30. PubMed ID: 20190247
    [Abstract] [Full Text] [Related]

  • 20. Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients With Chronic Heart Failure and Iron Deficiency.
    Charles-Edwards G, Amaral N, Sleigh A, Ayis S, Catibog N, McDonagh T, Monaghan M, Amin-Youssef G, Kemp GJ, Shah AM, Okonko DO.
    Circulation; 2019 May 21; 139(21):2386-2398. PubMed ID: 30776909
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.